Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2025-12-25 @ 4:11 AM
NCT ID:
NCT07296120
Eligibility Criteria:
Inclusion Criteria:
* Age 18 years or older
* Diagnosis of hematological malignancy
* Treatment with HSCT or CAR-T therapy
* Must be able to give informed consent
* Must be willing to provide blood samples after HSCT or CAR-T therapy and prior to vaccination
* Must be willing to provide blood samples at four weeks and six months post-vaccination
* Must have an insurance plan that covers the cost of recieving the RSV vaccine.
Exclusion Criteria:
* History of a severe allergic reaction to any component of the RSV vaccine
* Use of intravenous immunoglobulin (IVIG) for hypogammaglobulinemia within the past six months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07296120
Study Brief:
Protocol Section:
NCT07296120